COMPANY

Conceivable Life Sciences

HQ: New York, NY source · conceivable.life ↗

Conceivable Life Sciences Inc. is a biotechnology and life sciences company that develops and operates proprietary technology that automates in vitro fertilization (IVF) laboratory processes. Our services may include, but are not limited to, our Site, software platforms, data analytics tools, and related technical services (collectively, “Services”). From company website Source · Oct 13, 2026

Keywords: life sciences Infertility AURA assisted ART treatment Gamete preparation, ICSI, embryo culture and vitrification robot assistant

Profile checked Oct 10, 2026

$68.0MRaised (2 yrs)3Trials (company is sponsor)

Timeline

Oct 14, 2025 Trial start Not phased (device or behavioral study): Automation of Oocyte and Embryo Vitrification source ↗
Sep 15, 2025 Raise Private equity round — Series A: $50M (total, as published), announced Sep 15, 2025. Source: company's own press page. source ↗
Jan 14, 2025 Raise Private equity round — Series A: $18M (total, as published), announced Jan 14, 2025. Source: company release on GlobeNewswire. source ↗
Dec 3, 2024 Trial start Not phased (device or behavioral study): Automation of the In Vitro Fertilization Laboratory source ↗
Oct 30, 2023 Trial start Not phased (device or behavioral study): Automation of Gamete Preparation, Intracytoplasmic Sperm Injection (ICSI), Embryo Culture, and Vitrification source ↗

Upcoming milestones

2026-10 (ESTIMATED) · Not phased · Automation of the In Vitro Fertilization Laboratory · NCT06581068

Estimated primary completion per ClinicalTrials.gov. Dates move.

Funding

Raised: $68.0M. Last 2 years.

Sep 15, 2025 Private equity round — Series A: $50M (total, as published), announced Sep 15, 2025. Source: company's own press page. source ↗
Jan 14, 2025 Private equity round — Series A: $18M (total, as published), announced Jan 14, 2025. Source: company release on GlobeNewswire. source ↗

Clinical trials (lead sponsor) 3

Record	Title	Phase	Status	Start	Primary completion
NCT06581068	Automation of the In Vitro Fertilization Laboratory	Not phased (device or behavioral study)	Recruiting	Dec 3, 2024	2026-10 (estimated)
NCT07197983	Automation of Oocyte and Embryo Vitrification	Not phased (device or behavioral study)	Recruiting	Oct 14, 2025	Jun 30, 2026 (estimated)
NCT06074835	Automation of Gamete Preparation, Intracytoplasmic Sperm Injection (ICSI), Embryo Culture, and Vitrification	Not phased (device or behavioral study)	Completed	Oct 30, 2023	Oct 3, 2024 (actual)

Connect

Contact page